NervGen Pharma Statistics

Total Valuation

NervGen Pharma has a market cap or net worth of CAD 210.92 million. The enterprise value is 190.05 million.

Market Cap	210.92M
Enterprise Value	190.05M

Important Dates

The next estimated earnings date is Thursday, February 27, 2025.

Earnings Date	Feb 27, 2025
Ex-Dividend Date	n/a

Share Statistics

NervGen Pharma has 70.31 million shares outstanding. The number of shares has increased by 9.52% in one year.

Current Share Class	n/a
Shares Outstanding	70.31M
Shares Change (YoY)	+9.52%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	2.82%
Owned by Institutions (%)	4.16%
Float	58.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	22.94
P/TBV Ratio	24.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.92
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.01.

Current Ratio	1.66
Quick Ratio	1.59
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -336.09% and return on invested capital (ROIC) is -196.47%.

Return on Equity (ROE)	-336.09%
Return on Assets (ROA)	-74.07%
Return on Capital (ROIC)	-196.47%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +78.57% in the last 52 weeks. The beta is 1.33, so NervGen Pharma's price volatility has been higher than the market average.

Beta (5Y)	1.33
52-Week Price Change	+78.57%
50-Day Moving Average	2.56
200-Day Moving Average	2.51
Relative Strength Index (RSI)	58.51
Average Volume (20 Days)	60,672

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-23.00M
Pretax Income	-24.01M
Net Income	-24.01M
EBITDA	-23.01M
EBIT	-23.00M
Earnings Per Share (EPS)	-0.37

Full Income Statement

Balance Sheet

The company has 21.01 million in cash and 129,016 in debt, giving a net cash position of 20.88 million or 0.30 per share.

Cash & Cash Equivalents	21.01M
Total Debt	129,016
Net Cash	20.88M
Net Cash Per Share	0.30
Equity (Book Value)	9.18M
Book Value Per Share	0.13
Working Capital	8.70M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-16.27M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NervGen Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.52%
Shareholder Yield	-9.52%
Earnings Yield	-12.36%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a